Biotech · Private company
R-Pharm
Track this companyFree. Adds R-Pharm to your Dealase workspace and tells you when its record changes.
Clinical trials90 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- CapecitabinePhase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- CapecitabinePhase 3 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- Ixabepilone + CapecitabinePhase 3 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- Ixabepilone + CapecitabinePhase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Carboplatin (area under the concentration curve [AUC] 6)Phase 2 · Advanced/Metastatic Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Ixabepilone, 32 mg/m^2Phase 2 · Advanced/Metastatic Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Paclitaxel, 200 mg/m^2Phase 2 · Advanced/Metastatic Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- CisplatinPhase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- ixabepilonePhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- IxabepilonePhase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- IxabepilonePhase 1 · Solid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- RifampinPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial InfarctionPHASE2 · COMPLETED · started Dec 7, 2020ClinicalTrials.gov NCT04463251 · fetched Nov 12, 2026
- Evaluation of Weekly Ixabepilone With or Without Biweekly BevacizumabPHASE2 · COMPLETED · started Apr 3, 2017ClinicalTrials.gov NCT03093155 · fetched Nov 12, 2026
- Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056PHASE2 · TERMINATED · started Mar 7, 2011ClinicalTrials.gov NCT01296711 · fetched Nov 12, 2026
- Phase I Combination Ixabepilone + CisplatinPHASE1 · COMPLETED · started May 1, 2009ClinicalTrials.gov NCT00832117 · fetched Nov 12, 2026
- A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung CancerPHASE2 · COMPLETED · started Dec 1, 2008ClinicalTrials.gov NCT00723957 · fetched Nov 12, 2026
- Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.PHASE1 · COMPLETED · started Sep 1, 2005ClinicalTrials.gov NCT00162136 · fetched Nov 12, 2026
- Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced CancerPHASE1 · COMPLETED · started Sep 1, 2005ClinicalTrials.gov NCT00207090 · fetched Nov 12, 2026
- Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerPHASE3 · COMPLETED · started Nov 1, 2003ClinicalTrials.gov NCT00082433 · fetched Nov 12, 2026
- Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerPHASE3 · COMPLETED · started Sep 1, 2003ClinicalTrials.gov NCT00080301 · fetched Nov 12, 2026